Skip to content
value.today

Huya Bioscience International, LLC

🇺🇸 San Diego, California, USABiotechnologyFounded 2005
Total raised
$13 M
2 rounds on record
Latest round
$8 M
Mar 2011
First round on record
Jul 2007
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Huya Bioscience International, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2011$8 MNo. 2$2 to $10 million

Huya Bioscience International, LLC: Raise no. 2, Mar 2011

Investors in this round

6 investors had bought by the notice of Apr 2, 2012: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $18 M offered; $10 M still to sell
Smallest investment taken
$1,000,000
What was sold
equity, debt
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Clement M Gingras · Executive Officer, Director
  • Derek M Winstanley · Executive Officer
  • Mireille Gingras · Executive Officer, Director
  • Sabrina Martucci Johnson · Executive Officer
  • Robert M Haimsohn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$3,000,000 of Total Offering Amount is a promissory note that will convert into units.”

Signed by Sabrina M. Johnson, Acting Chief Financial Officer and Chief Operations Officer. Source: SEC Form D, newest notice filed Apr 2, 2012. Read the notice at the SEC.

equity, debtSEC
Jul 2007$5 MNo. 1$2 to $10 million

Huya Bioscience International, LLC: Raise no. 1, Jul 2007

Investors in this round

12 investors had bought by the notice of Apr 7, 2009: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$39,990
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in De

People named in the notice

  • Mireille Gingras · Executive Officer, Director
  • Clement Gingras · Director
  • Robert M Haimsohn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mireille Gingras, Ph.D, Ceo. Source: SEC Form D, newest notice filed Apr 7, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Huya Bioscience International, LLC chose not to state its revenue in its newest notice of a funding round (Apr 2012).

    SEC Form D · Apr 2012

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2012

That is all the official record says: Huya Bioscience International, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Huya Bioscience International, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 12 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Huya Bioscience International, LLC
NameRoleNamed in
Clement M GingrasExecutive officerApr 2012
Derek M WinstanleyExecutive officerApr 2012
Mireille GingrasExecutive officerApr 2012
Sabrina Martucci JohnsonExecutive officerApr 2012
Clement M GingrasDirectorApr 2012
Mireille GingrasDirectorApr 2012
Robert M HaimsohnDirectorApr 2012
Clement GingrasDirectorApr 2009